AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/222
CHEMOTHERAPY IMMEDIATELY FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: RAHMAN Z KAVANAGH J CHAMPLIN R GILES R HANANIA E FU SQ ZU ZF MEHRA R HOLMES F KUDELKA A CLAXTON D VERSCHRAEGEN C GAJEWSKI J ANDREEFF M HEIMFELD S BERENSON R ELLERSON D CALVERT L MECHETNER E HOLZMAYER T DAYNE A HAMER J BACHIER C OSTROVE J PRZEPIORKA D BURTNESS B COTE R BAST R HORTOBAGYI G DEISSEROTH A
Citation: Z. Rahman et al., CHEMOTHERAPY IMMEDIATELY FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER, Clinical cancer research, 4(11), 1998, pp. 2717-2721
RESCUE FROM APOPTOSIS IN EARLY (CD34-SELECTED) VERSUS LATE (NON-CD34-SELECTED) HUMAN HEMATOPOIETIC-CELLS BY VERY LATE ANTIGEN 4-DEPENDENT AND VASCULAR CELL-ADHESION MOLECULE (VCAM) 1-DEPENDENT ADHESION TO BONE-MARROW STROMAL CELLS
Authors: WANG MWJ CONSOLI U LANE CM DURETT A LAUPPE MJ CHAMPLIN R ANDREEFF M DEISSEROTH AB
Citation: Mwj. Wang et al., RESCUE FROM APOPTOSIS IN EARLY (CD34-SELECTED) VERSUS LATE (NON-CD34-SELECTED) HUMAN HEMATOPOIETIC-CELLS BY VERY LATE ANTIGEN 4-DEPENDENT AND VASCULAR CELL-ADHESION MOLECULE (VCAM) 1-DEPENDENT ADHESION TO BONE-MARROW STROMAL CELLS, Cell growth & differentiation, 9(2), 1998, pp. 105-112
TRANSPLANT-LITE - INDUCTION OF GRAFT-VERSUS-MALIGNANCY USING FLUDARABINE-BASED NONABLATIVE CHEMOTHERAPY AND ALLOGENEIC BLOOD PROGENITOR-CELL TRANSPLANTATION AS TREATMENT FOR LYMPHOID MALIGNANCIES
Authors: KHOURI IF KEATING M KORBLING M PRZEPIORKA D ANDERLINI P OBRIEN S GIRALT S IPPOLITI C VONWOLFF B GAJEWSKI J DONATO M CLAXTON D UENO N ANDERSSON B GEE A CHAMPLIN R
Citation: If. Khouri et al., TRANSPLANT-LITE - INDUCTION OF GRAFT-VERSUS-MALIGNANCY USING FLUDARABINE-BASED NONABLATIVE CHEMOTHERAPY AND ALLOGENEIC BLOOD PROGENITOR-CELL TRANSPLANTATION AS TREATMENT FOR LYMPHOID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2817-2824
HIGH-DOSE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - MEDIASTINAL LOCALIZATION PREDICTS FOR A FAVORABLE OUTCOME
Authors: POPAT U PRZEPIORK D CHAMPLIN R PUGH W AMIN K MEHRA R RODRIGUEZ J GIRALT S ROMAGUERA J RODRIGUEZ A PRETI A ANDERSSON B KHOURI I CLAXTON D DELIMA M DONATO M ANDERLINI P GAJEWSKI J CABANILLAS F VANBESIEN K
Citation: U. Popat et al., HIGH-DOSE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - MEDIASTINAL LOCALIZATION PREDICTS FOR A FAVORABLE OUTCOME, Journal of clinical oncology, 16(1), 1998, pp. 63-69
ALLOGENEIC MARROW TRANSPLANTATION FOR MYELOPROLIFERATIVE DISORDERS OTHER THAN CHRONIC MYELOGENOUS LEUKEMIA - REVIEW OF 40 CASES
Authors: PRZEPIORKA D GIRALT S KHOURI I CHAMPLIN R BUESORAMOS C
Citation: D. Przepiorka et al., ALLOGENEIC MARROW TRANSPLANTATION FOR MYELOPROLIFERATIVE DISORDERS OTHER THAN CHRONIC MYELOGENOUS LEUKEMIA - REVIEW OF 40 CASES, American journal of hematology, 57(1), 1998, pp. 24-28
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH BREAST-CANCER
Authors: RAHMAN ZU HORTOBAGYI GN BUZDAR AU CHAMPLIN R
Citation: Zu. Rahman et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH BREAST-CANCER, Cancer treatment reviews, 24(4), 1998, pp. 249-263
PHASE-II STUDY OF DACLIZUMAB FOR TREATMENT OF ACUTE GRAFT-VS-HOST DISEASE
Authors: PRZEPIORKA D KERNAN N IPPOLITI C PAPADOPOULOS E GIRALT S KHOURI I LU J GAJEWSKI J DURETT A CLEARY R CHAMPLIN R ANDERSSON B LIGHT S
Citation: D. Przepiorka et al., PHASE-II STUDY OF DACLIZUMAB FOR TREATMENT OF ACUTE GRAFT-VS-HOST DISEASE, Experimental hematology, 26(8), 1998, pp. 35-35
PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING INTENSIVE CHEMOTHERAPY WITH GROWTH-FACTOR (GF) OR PERIPHERAL-BLOOD PROGENITOR (PBPC) CELL MOBILIZATION TO GROWTH-FACTOR ALONE FOR HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY (HDC)
Authors: GAJEWSKI J RONDON G MIRZA N MEHRA R DONATO M ANDERLINI P KORBLING M THERIALT R KHOURI I GIRALT S BUZDAR A UENO N PRZEPIORKA D ANDERSSON B DURRETT A SALIBA R BRUTON J RAHMAN Z IPPOLITI C HORTABAQYI G RABER M BAST R CHAMPLIN R
Citation: J. Gajewski et al., PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING INTENSIVE CHEMOTHERAPY WITH GROWTH-FACTOR (GF) OR PERIPHERAL-BLOOD PROGENITOR (PBPC) CELL MOBILIZATION TO GROWTH-FACTOR ALONE FOR HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY (HDC), Experimental hematology, 26(8), 1998, pp. 371-371
INDUCTION OF GRAFT-VS-MALIGNANCY AS A PRIMARY THERAPEUTIC MODALITY
Authors: CHAMPLIN R KHOURI I GIRALT S
Citation: R. Champlin et al., INDUCTION OF GRAFT-VS-MALIGNANCY AS A PRIMARY THERAPEUTIC MODALITY, Experimental hematology, 26(8), 1998, pp. 486-486
TRANSFUSION SUPPORT USING FILTERED UNSCREENED BLOOD PRODUCTS FOR CYTOMEGALOVIRUS-NEGATIVE ALLOGENEIC MARROW TRANSPLANT RECIPIENTS
Authors: NARVIOS AB PRZEPIORKA D TARRAND J CHAN KW CHAMPLIN R LICHTIGER B
Citation: Ab. Narvios et al., TRANSFUSION SUPPORT USING FILTERED UNSCREENED BLOOD PRODUCTS FOR CYTOMEGALOVIRUS-NEGATIVE ALLOGENEIC MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 22(6), 1998, pp. 575-577
ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION - A REPLACEMENT FOR BONE-MARROW TRANSPLANTATION
Authors: KORBLING M PRZEPIORKA D ANDERLINI P CHAMPLIN R
Citation: M. Korbling et al., ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION - A REPLACEMENT FOR BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 19-19
IMPACT OF PROPHYLAXIS REGIMEN ON THE INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION
Authors: PRZEPIORKA D IPPOLITI C KHOURI I ANDERLINI P FOLLODER J UENO N MEHRA R GIRALT S GAJEWSKI J CLEARY K CLAXTON D CHAMPLIN R ANDERSSON B KORBLING M
Citation: D. Przepiorka et al., IMPACT OF PROPHYLAXIS REGIMEN ON THE INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 26-26
BLOOD STEM-CELL PROCUREMENT - DONOR SAFETY ISSUES
Authors: ANDERLINI P PRZEPIORKA D KORBLING M CHAMPLIN R
Citation: P. Anderlini et al., BLOOD STEM-CELL PROCUREMENT - DONOR SAFETY ISSUES, Bone marrow transplantation, 21, 1998, pp. 35-39
PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) VERSUS BONE-MARROW (BM) TRANSPLANTS FROM HLA-IDENTICAL DONORS - A JOINT ANALYSIS OF THE INTERNATIONAL BONE-MARROW TRANSPLANT REGISTRY (IBMTR) AND THE UROPEAN-GROUP-FOR-BLOOD-AND-MARROW-TRANSPLANTATION (EBMT)
Authors: SCHMITZ N CHAMPLIN R HOROWITZ M GRATWOHL A
Citation: N. Schmitz et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) VERSUS BONE-MARROW (BM) TRANSPLANTS FROM HLA-IDENTICAL DONORS - A JOINT ANALYSIS OF THE INTERNATIONAL BONE-MARROW TRANSPLANT REGISTRY (IBMTR) AND THE UROPEAN-GROUP-FOR-BLOOD-AND-MARROW-TRANSPLANTATION (EBMT), Bone marrow transplantation, 21, 1998, pp. 155-155
ALLOGENEIC STEM-CELL TRANSPLANTATION FOR ADVANCED HODGKINS-DISEASE - THE ANDERSON,M.D. EXPERIENCE
Authors: ANDERLINI P ANDERSSON B GAJEWSKI J GIRALT S MEHRA R CLAXTON D UENO N KHOURI I PRZEPIORKA D DONATO M KORBLING M CHAMPLIN R
Citation: P. Anderlini et al., ALLOGENEIC STEM-CELL TRANSPLANTATION FOR ADVANCED HODGKINS-DISEASE - THE ANDERSON,M.D. EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 575-575
PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) APHERESIS - 4-YEAR RESULTS OFTHE M.D.-ANDERSON-COLLECTION PROTOCOL IN NORMAL DONORS
Authors: ANDERLINI P DONATO M LAUPPE MJ HUH YO CHAMPLIN R KORBLING M
Citation: P. Anderlini et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) APHERESIS - 4-YEAR RESULTS OFTHE M.D.-ANDERSON-COLLECTION PROTOCOL IN NORMAL DONORS, Transfusion, 38(10), 1998, pp. 357-357
PREDICTORS OF HEPATIC VENOOCCLUSIVE DISEASE AFTER BONE-MARROW TRANSPLANTATION-CASE DEFINITION BASED ON SEATTLE CRITERIA
Authors: BILICI A BOLUKOGLU H CONNELL TK GALATI J AHN C CHAMPLIN R GLOBER G ANKOMASEY V
Citation: A. Bilici et al., PREDICTORS OF HEPATIC VENOOCCLUSIVE DISEASE AFTER BONE-MARROW TRANSPLANTATION-CASE DEFINITION BASED ON SEATTLE CRITERIA, Gastroenterology, 114(4), 1998, pp. 54-54
RISE FACTORS OF HEPATIC VENOOCCLUSIVE DISEASE IN BONE-MARROW TRANSPLANT PATIENTS AS DIAGNOSED BY BALTIMORE CLINICAL DIAGNOSTIC-CRITERIA
Authors: BILICI A BOLUKOGLU H CONNELL TK GALATI J AHN C CHAMPLIN R GLOBER G ANKOMASEY V
Citation: A. Bilici et al., RISE FACTORS OF HEPATIC VENOOCCLUSIVE DISEASE IN BONE-MARROW TRANSPLANT PATIENTS AS DIAGNOSED BY BALTIMORE CLINICAL DIAGNOSTIC-CRITERIA, Gastroenterology, 114(4), 1998, pp. 55-55
PRELIMINARY-REPORT OF A NEW ACTIVE REGIMEN FOR AGGRESSIVE MANTLE CELLLYMPHOMA
Authors: KHOURI IF ROMAGUERA J PALMER JL PUGH WC KORBLING M SAMUELS B GIRALT S RODRIGUEZ A PRZEPIORKA D MCLAUGHLIN P ANDERSSON B CLAXTON D MIRZA N MEHRA R HAGEMEISTER F CABANILLAS F CHAMPLIN R
Citation: If. Khouri et al., PRELIMINARY-REPORT OF A NEW ACTIVE REGIMEN FOR AGGRESSIVE MANTLE CELLLYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 240-241
PROGNOSTIC VALUE OF CYTOGENETICS IN MULTIPLE-MYELOMA
Authors: SEONG C DELASALLE K HAYES K WEBER D DIMOPOULOS M SWANTKOWSKI J HUH Y GLASSMAN A CHAMPLIN R ALEXANIAN R
Citation: C. Seong et al., PROGNOSTIC VALUE OF CYTOGENETICS IN MULTIPLE-MYELOMA, British Journal of Haematology, 101(1), 1998, pp. 189-194
A MULTICENTER STUDY OF PLATELET RECOVERY AND UTILIZATION IN PATIENTS AFTER MYELOABLATIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: BERNSTEIN SH NADEMANEE AP VOSE JM TRICOT G FAY JW NEGRIN RS DIPERSIO J RONDON G CHAMPLIN R BARNETT MJ CORNETTA K HERZIG GP VAUGHAN W GEILS G KEATING J MESSNER H WOLFF SN MILLER KB LINKER C CAIRO M HELLMANN S ASHBY M STRYKER S NASH RA
Citation: Sh. Bernstein et al., A MULTICENTER STUDY OF PLATELET RECOVERY AND UTILIZATION IN PATIENTS AFTER MYELOABLATIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Blood, 91(9), 1998, pp. 3509-3517
ACTIVITY OF INTERLEUKIN-2 IN NON-HODGKINS-LYMPHOMA FOLLOWING TRANSPLANTATION OF INTERLEUKIN-2-ACTIVATED AUTOLOGOUS BONE-MARROW OR STEM-CELLS
Authors: VANBESIEN K MARGOLIN K CHAMPLIN R FORMAN S
Citation: K. Vanbesien et al., ACTIVITY OF INTERLEUKIN-2 IN NON-HODGKINS-LYMPHOMA FOLLOWING TRANSPLANTATION OF INTERLEUKIN-2-ACTIVATED AUTOLOGOUS BONE-MARROW OR STEM-CELLS, The cancer journal from Scientific American, 3, 1997, pp. 54-58
ANALYSIS OF CHIMERISM FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION BY FLUORESCENT-IN-SITU HYBRIDIZATION
Authors: RONDON G GIRALT S PEREIRA M VANBESIEN K MEHRA R CHAMPLIN R ANDREEFF M
Citation: G. Rondon et al., ANALYSIS OF CHIMERISM FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION BY FLUORESCENT-IN-SITU HYBRIDIZATION, Leukemia & lymphoma, 25(5-6), 1997, pp. 463-467
CENTRAL-NERVOUS-SYSTEM RELAPSE OF LYMPHOID MALIGNANCIES IN ADULTS - THE ROLE OF HIGH-DOSE CHEMOTHERAPY
Authors: VANBESIEN K FORMAN A CHAMPLIN R
Citation: K. Vanbesien et al., CENTRAL-NERVOUS-SYSTEM RELAPSE OF LYMPHOID MALIGNANCIES IN ADULTS - THE ROLE OF HIGH-DOSE CHEMOTHERAPY, Annals of oncology, 8(6), 1997, pp. 515-524
NOSOCOMIAL RESPIRATORY SYNCYTIAL VIRUS-INFECTIONS - PREVENTION AND CONTROL IN BONE-MARROW TRANSPLANT PATIENTS
Authors: GARCIA R RAAD I ABISAID D BODEY G CHAMPLIN R TARRAND J HILL LA UMPHREY J NEUMANN J ENGLUND J WHIMBEY E
Citation: R. Garcia et al., NOSOCOMIAL RESPIRATORY SYNCYTIAL VIRUS-INFECTIONS - PREVENTION AND CONTROL IN BONE-MARROW TRANSPLANT PATIENTS, Infection control and hospital epidemiology, 18(6), 1997, pp. 412-416
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>